Opto Circuits is currently trading at Rs 61.35, up by 1.05 points or 1.74% from its previous closing of Rs 60.30 on the BSE.
The scrip opened at Rs 60.40 and has touched a high and low of Rs 63.25 and Rs 58.50 respectively. So far 1547076 shares were traded on the counter.
The BSE group 'A' stock of face value Rs 10 has touched a 52 week high of Rs 216.90 on 29-Mar-2012 and a 52 week low of Rs 43.15 on 27-Feb-2013.
Last one week high and low of the scrip stood at Rs 64.00 and Rs 46.65 respectively. The current market cap of the company is Rs 1484.21 crore.
The promoters holding in the company stood at 28.17% while Institutions and Non-Institutions held 39.09% and 32.74% respectively.
Opto Circuits’ subsidiary, Cardiac Science, has signed a definitive agreement to sell its Diagnostic Cardiology product line to Mortara Instrument, Inc. for an estimated consideration of $21 million.
The transaction does not include MySense, the novel, wearable, single patient ECG recorder system and the resuscitation business unit that markets automated external defibrillators (AEDs) worldwide.
Opto Circuits India is a multinational medical device company headquartered out of Bengaluru, India. The company designs, develop, manufacture, market and distribute a range of medical products that are used by healthcare establishments in more than 150 countries.
| Company Name | CMP |
|---|---|
| Lenskart Solutions | 534.85 |
| Poly Medicure | 1468.25 |
| Laxmi Denta | 195.10 |
| Nureca Ltd. | 263.80 |
| Hemant Surgical Inds | 297.75 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: